Handelsbanken Fonder AB grew its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 2.4% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 293,470 shares of the semiconductor company’s stock after acquiring an additional 6,912 shares during the quarter. Handelsbanken Fonder AB’s holdings in Synopsys were worth $150,456,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of SNPS. Nuveen LLC purchased a new position in Synopsys in the first quarter valued at approximately $341,480,000. Generation Investment Management LLP acquired a new stake in shares of Synopsys in the first quarter worth $240,491,000. Vanguard Group Inc. raised its stake in shares of Synopsys by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after acquiring an additional 346,994 shares during the period. Alliancebernstein L.P. boosted its position in Synopsys by 22.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after purchasing an additional 313,218 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Synopsys by 20.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after purchasing an additional 305,489 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Price Performance
SNPS stock opened at $385.60 on Friday. The stock’s 50 day moving average is $445.10 and its two-hundred day moving average is $510.75. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a market capitalization of $71.62 billion, a PE ratio of 30.27, a P/E/G ratio of 5.02 and a beta of 1.10. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52.
Analyst Upgrades and Downgrades
SNPS has been the topic of several research reports. Morgan Stanley cut their price objective on Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research report on Thursday, September 11th. The Goldman Sachs Group dropped their target price on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. BNP Paribas started coverage on Synopsys in a report on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price target for the company. JPMorgan Chase & Co. lowered their price objective on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Finally, Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, Synopsys has a consensus rating of “Hold” and a consensus price target of $562.14.
View Our Latest Research Report on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the sale, the chief executive officer owned 71,615 shares in the company, valued at $42,181,951.15. This represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $609.77, for a total value of $2,228,709.35. Following the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. This represents a 19.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,894 shares of company stock worth $16,760,783 over the last quarter. Company insiders own 0.62% of the company’s stock.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
- Differences Between Momentum Investing and Long Term Investing
- Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
